Barinthus Biotherapeutics plc.
BRNSDelisted Sep 9, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828185
Barinthus Biotherapeutics plc. was delisted on Sep 9, 2026; its insiders filed their last Form 4 on Sep 11, 2026; 15 institutions reported holding it in 13F filings for Q2 2026, worth $7.84M in total; no superinvestor held it.
13F holders, Q2 2021
Institutional positions in Barinthus Biotherapeutics plc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +19 vs. Q1 2021
- Shares held
- 4.63M
- +4.63M vs. Q1 2021
- Total value
- $76.8M
- +$76.8M vs. Q1 2021
- New holders
- 19
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BRNS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $7.84M |
| Q1 2026 | 14 | $7.89M |
| Q4 2025 | 13 | $6.10M |
| Q3 2025 | 15 | $10.4M |
| Q2 2025 | 14 | $9.02M |
| Q1 2025 | 15 | $9.15M |
| Q4 2024 | 16 | $10.3M |
| Q3 2024 | 19 | $10.7M |
| Q2 2024 | 18 | $11.8M |
| Q1 2024 | 15 | $21.3M |
| Q4 2023 | 15 | $36.5M |
| Q3 2023 | 16 | $29.5M |
| Q2 2023 | 15 | $20.0M |
| Q1 2023 | 13 | $21.6M |
| Q4 2022 | 15 | $22.2M |
| Q3 2022 | 11 | $31.2M |
| Q2 2022 | 13 | $27.5M |
| Q1 2022 | 12 | $23.8M |
| Q4 2021 | 15 | $54.3M |
| Q3 2021 | 15 | $77.6M |
| Q2 2021 | 19 | $76.8M |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Barinthus Biotherapeutics plc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ETF Managers Group, LLC | 10,113 | $145.0K | 0.00% | +10,113 | New |
| Capstone Investment Advisors, LLC | 10,000 | $168.0K | 0.00% | +10,000 | New |
| Ghisallo Capital Management LLC | 10,000 | $168.0K | 0.01% | +10,000 | New |
| Cubist Systematic Strategies, LLC | 11,562 | $194.0K | 0.00% | +11,562 | New |
| Morgan Stanley | 16,881 | $284.0K | 0.00% | +16,881 | New |
| Brookfield Asset Management Inc. | 25,000 | $420.0K | 0.00% | +25,000 | New |
| Squarepoint Ops LLC | 25,000 | $420.0K | 0.00% | +25,000 | New |
| Arena Capital Advisors, LLC- CA | 30,698 | $515.0K | 0.04% | +30,698 | New |
| Vontobel Holding Ltd. | 40,000 | $671.0K | 0.01% | +40,000 | New |
| Ipswich Investment Management Co., Inc. | 43,275 | $726.0K | 0.19% | +43,275 | New |
| BlackRock Inc. | 49,927 | $839.0K | 0.00% | +49,927 | New |
| Caas Capital Management LP | 50,000 | $839.0K | 0.04% | +50,000 | New |
| Millennium Management LLC | 130,137 | $2.18M | 0.00% | +130,137 | New |
| Monashee Investment Management LLC | 132,184 | $2.22M | 0.27% | +132,184 | New |
| Hudson Bay Capital Management LP | 189,301 | $3.10M | 0.04% | +189,301 | New |
| Tudor Investment Corp Et Al | 420,319 | $6.01M | 0.12% | +420,319 | New |
| DC Funds, LP | 642,204 | $10.8M | 51.19% | +642,204 | New |
| M&G Investment Management Ltd | 1,088,597 | $18.5M | 0.10% | +1,088,597 | New |
| Alphabet Inc. | 1,704,444 | $28.6M | 0.58% | +1,704,444 | New |